196 related articles for article (PubMed ID: 10935481)
1. Application of comparative genomic hybridization, spectral karyotyping, and microarray analysis in the identification of subtype-specific patterns of genomic changes in rhabdomyosarcoma.
Pandita A; Zielenska M; Thorner P; Bayani J; Godbout R; Greenberg M; Squire JA
Neoplasia; 1999 Aug; 1(3):262-75. PubMed ID: 10935481
[TBL] [Abstract][Full Text] [Related]
2. Gains, losses, and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization.
Weber-Hall S; Anderson J; McManus A; Abe S; Nojima T; Pinkerton R; Pritchard-Jones K; Shipley J
Cancer Res; 1996 Jul; 56(14):3220-4. PubMed ID: 8764111
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal and genetic imbalances in Chinese patients with rhabdomyosarcoma detected by high-resolution array comparative genomic hybridization.
Liu C; Li D; Hu J; Jiang J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
Int J Clin Exp Pathol; 2014; 7(2):690-8. PubMed ID: 24551291
[TBL] [Abstract][Full Text] [Related]
4. [Comparative genomic hybridization: the profile of chromosomal imbalances in rhabdomyosarcoma].
Li QX; Liu CX; Chun CP; Qi Y; Chang B; Nong WX; Yao ES; Li HA; Li F
Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):536-41. PubMed ID: 19094465
[TBL] [Abstract][Full Text] [Related]
5. Combined spectral karyotyping, multicolor banding, and microarray comparative genomic hybridization analysis provides a detailed characterization of complex structural chromosomal rearrangements associated with gene amplification in the osteosarcoma cell line MG-63.
Lim G; Karaskova J; Vukovic B; Bayani J; Beheshti B; Bernardini M; Squire JA; Zielenska M
Cancer Genet Cytogenet; 2004 Sep; 153(2):158-64. PubMed ID: 15350306
[TBL] [Abstract][Full Text] [Related]
6. Analysis of molecular cytogenetic alteration in rhabdomyosarcoma by array comparative genomic hybridization.
Liu C; Li D; Jiang J; Hu J; Zhang W; Chen Y; Cui X; Qi Y; Zou H; Zhang W; Li F
PLoS One; 2014; 9(4):e94924. PubMed ID: 24743780
[TBL] [Abstract][Full Text] [Related]
7. Molecular cytogenetic characterization of rhabdomyosarcoma cell lines.
Rodriguez-Perales S; Martínez-Ramírez A; de Andrés SA; Valle L; Urioste M; Benítez J; Cigudosa JC
Cancer Genet Cytogenet; 2004 Jan; 148(1):35-43. PubMed ID: 14697639
[TBL] [Abstract][Full Text] [Related]
8. Novel genomic imbalances in embryonal rhabdomyosarcoma revealed by comparative genomic hybridization and fluorescence in situ hybridization: an intergroup rhabdomyosarcoma study.
Bridge JA; Liu J; Weibolt V; Baker KS; Perry D; Kruger R; Qualman S; Barr F; Sorensen P; Triche T; Suijkerbuijk R
Genes Chromosomes Cancer; 2000 Apr; 27(4):337-44. PubMed ID: 10719362
[TBL] [Abstract][Full Text] [Related]
9. Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.
Missiaglia E; Selfe J; Hamdi M; Williamson D; Schaaf G; Fang C; Koster J; Summersgill B; Messahel B; Versteeg R; Pritchard-Jones K; Kool M; Shipley J
Genes Chromosomes Cancer; 2009 Jun; 48(6):455-67. PubMed ID: 19235922
[TBL] [Abstract][Full Text] [Related]
10. Genomic gains and losses are similar in genetic and histologic subsets of rhabdomyosarcoma, whereas amplification predominates in embryonal with anaplasia and alveolar subtypes.
Bridge JA; Liu J; Qualman SJ; Suijkerbuijk R; Wenger G; Zhang J; Wan X; Baker KS; Sorensen P; Barr FG
Genes Chromosomes Cancer; 2002 Mar; 33(3):310-21. PubMed ID: 11807989
[TBL] [Abstract][Full Text] [Related]
11. Molecular cytogenetic analysis of non-small cell lung carcinoma by spectral karyotyping and comparative genomic hybridization.
Luk C; Tsao MS; Bayani J; Shepherd F; Squire JA
Cancer Genet Cytogenet; 2001 Mar; 125(2):87-99. PubMed ID: 11369051
[TBL] [Abstract][Full Text] [Related]
12. Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.
Barr FG; Duan F; Smith LM; Gustafson D; Pitts M; Hammond S; Gastier-Foster JM
Genes Chromosomes Cancer; 2009 Aug; 48(8):661-72. PubMed ID: 19422036
[TBL] [Abstract][Full Text] [Related]
13. Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.
Goldstein M; Meller I; Issakov J; Orr-Urtreger A
Neoplasia; 2006 May; 8(5):332-43. PubMed ID: 16790082
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
15. Molecular cytogenetic analysis of head and neck squamous cell carcinoma: By comparative genomic hybridization, spectral karyotyping, and expression array analysis.
Squire JA; Bayani J; Luk C; Unwin L; Tokunaga J; MacMillan C; Irish J; Brown D; Gullane P; Kamel-Reid S
Head Neck; 2002 Sep; 24(9):874-87. PubMed ID: 12211052
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic studies in subgroups of rhabdomyosarcoma.
Whang-Peng J; Knutsen T; Theil K; Horowitz ME; Triche T
Genes Chromosomes Cancer; 1992 Nov; 5(4):299-310. PubMed ID: 1283318
[TBL] [Abstract][Full Text] [Related]
17. Identification of the 12q15 amplicon within the homogeneously staining regions in the embryonal rhabdomyosarcoma cell line RMS-YM.
Kakazu N; Yamane H; Miyachi M; Shiwaku K; Hosoi H
Cytogenet Genome Res; 2014; 142(3):167-73. PubMed ID: 24480864
[TBL] [Abstract][Full Text] [Related]
18. Cytogenetic-clinicopathologic correlations in rhabdomyosarcoma: a report of five cases.
Chen Z; Coffin CM; Smith LM; Issa B; Arndt S; Shepard R; Brothman L; Stratton J; Brothman AR; Zhou H
Cancer Genet Cytogenet; 2001 Nov; 131(1):31-6. PubMed ID: 11734315
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal imbalances in pleomorphic rhabdomyosarcomas and identification of the alveolar rhabdomyosarcoma-associated PAX3-FOXO1A fusion gene in one case.
Gordon A; McManus A; Anderson J; Fisher C; Abe S; Nojima T; Pritchard-Jones K; Shipley J
Cancer Genet Cytogenet; 2003 Jan; 140(1):73-7. PubMed ID: 12550764
[TBL] [Abstract][Full Text] [Related]
20. Integrated cytogenetic and high-resolution array CGH analysis of genomic alterations associated with MYCN amplification.
Pandita A; Bayani J; Paderova J; Marrano P; Graham C; Barrett M; Prasad M; Zielenska M; Squire JA
Cytogenet Genome Res; 2011; 134(1):27-39. PubMed ID: 21508638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]